Your browser doesn't support javascript.
loading
Association Between Social Vulnerability and SARS-CoV-2 Seroprevalence in Specimens Collected From Commercial Laboratories, United States, September 2021-February 2022.
Benoit, Tina J; Kim, Yun; Deng, Yangyang; Li, Zheng; Harding, Lee; Wiegand, Ryan; Deng, Xiaoyi; Jones, Jefferson M; Ronaldo, Iachan; Clarke, Kristie E N.
Afiliação
  • Benoit TJ; COVID-19 Response Team, Centers for Disease Control and Prevention, Atlanta, GA, USA.
  • Kim Y; ICF Inc, Fairfax, VA, USA.
  • Deng Y; ICF Inc, Fairfax, VA, USA.
  • Li Z; Office of Capacity Development and Applied Prevention Science, Agency for Toxic Substances and Disease Registry, Atlanta, GA, USA.
  • Harding L; ICF Inc, Fairfax, VA, USA.
  • Wiegand R; COVID-19 Response Team, Centers for Disease Control and Prevention, Atlanta, GA, USA.
  • Deng X; ICF Inc, Fairfax, VA, USA.
  • Jones JM; COVID-19 Response Team, Centers for Disease Control and Prevention, Atlanta, GA, USA.
  • Ronaldo I; ICF Inc, Fairfax, VA, USA.
  • Clarke KEN; COVID-19 Response Team, Centers for Disease Control and Prevention, Atlanta, GA, USA.
Public Health Rep ; : 333549231223140, 2024 Feb 15.
Article em En | MEDLINE | ID: mdl-38357883
ABSTRACT

OBJECTIVE:

We conducted a national US study of SARS-CoV-2 seroprevalence by Social Vulnerability Index (SVI) that included pediatric data and compared the Delta and Omicron periods during the COVID-19 pandemic. The objective of the current study was to assess the association between SVI and seroprevalence of infection-induced SARS-CoV-2 antibodies by period (Delta vs Omicron) and age group.

METHODS:

We used results of infection-induced SARS-CoV-2 antibody assays of clinical sera specimens (N = 406 469) from 50 US states from September 2021 through February 2022 to estimate seroprevalence overall and by county SVI tercile. Bivariate analyses and multilevel logistic regression models assessed the association of seropositivity with SVI and its themes by age group (0-17, ≥18 y) and period (Delta September-November 2021; Omicron December 2021-February 2022).

RESULTS:

Aggregate infection-induced SARS-CoV-2 antibody seroprevalence increased at all 3 SVI levels; it ranged from 25.8% to 33.5% in September 2021 and from 53.1% to 63.5% in February 2022. Of the 4 SVI themes, socioeconomic status had the strongest association with seroprevalence. During the Delta period, we found significantly more infections per reported case among people living in a county with high SVI (odds ratio [OR] = 2.76; 95% CI, 2.31-3.21) than in a county with low SVI (OR = 1.65; 95% CI, 1.33-1.97); we found no significant difference during the Omicron period. Otherwise, findings were consistent across subanalyses by age group and period.

CONCLUSIONS:

Among both children and adults, and during both the Delta and Omicron periods, counties with high SVI had significantly higher SARS-CoV-2 antibody seroprevalence than counties with low SVI did. These disparities reinforce SVI's value in identifying communities that need tailored prevention efforts during public health emergencies and resources to recover from their effects.
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Tipo de estudo: Prognostic_studies / Risk_factors_studies Idioma: En Ano de publicação: 2024 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Tipo de estudo: Prognostic_studies / Risk_factors_studies Idioma: En Ano de publicação: 2024 Tipo de documento: Article